Dr. O’Donnell develops radio-labeled monoclonal antibodies to treat lymphoma. He also is creating new chemotherapy and radioimmunotherapy combination protocols for treating non-Hodgkin’s lymphoma. He performs clinical trials in neuro-oncology and directs the Medical Oncology Brain-Tumor clinic.
Hematology and Oncology
M.D., Loyola University, Stritch School of Medicine, Maywood , Illinois, 1987
Ph.D., University of Illinois at Chicago, Chicago, Illinois, 1983
B.S., Loyola University, Chicago, Illinois, 1977
UC Davis Medical Center, Sacramento, California, 1987-90
UC Davis Medical Center, Sacramento, California, 1990-93
American Board of Internal Medicine, 1990
American Board of Internal Medicine, 2002
American Board of Internal Medicine, Medical Oncology, 1994
American Board of Internal Medicine, Medical Oncology, 2002
American Society of Clinical Oncology
Honors and Awards
U.S. Patent 62,180,089: "Avemar and Purified Low Molecular Weight Avemar Proteins for the Treatment of Non-Hodgkin's Lymphoma: Joseph Tuscano, MD and Robert O'Donnell, MD, PhD, 2010
U.S. Patent 6,217,871 "Antigenic Epitopes with Lym-1 Reactivity and Uses Thereof": Larry Rose, PhD, Claude Meares, PhD and Robert o"Donnell MD, PhD, 2001
American Cancer Society Clinical Fellowship, 1990
University of Illinois Graduate College Fellowship, 1983
Select Recent Publications
For a comprehensive list of Dr. O'Donnell's publications, please click here (opens new window).
2007 Semrad TJ, RT O'Donnell, T Wun, H Chew, D Harvey, H Zhou, RH White. Epidemiology of venous thromboembolism in 9489 patients with malignant glioma. J Neurosurg 106(4):601-608.